Cite

MLA Citation

    T. Smyth et al.. “Combined inhibition of SHP2 and ERK enhances anti-tumour effects in preclinical models.” European journal of cancer, vol. 138, n.d., pp. S44–S45. http://access.bl.uk/ark:/81055/vdc_100120047036.0x000019
  
Back to record